Results 31 to 40 of about 21,348 (217)

Role of Pneumonectomy in T1–4N2M0 Non-Small Cell Lung Cancer: A Propensity Score Matching Analysis

open access: yesFrontiers in Oncology, 2022
BackgroundN2 stage disease constitutes approximately 20%–30% of all non-small cell lung cancer (NSCLC). Concurrently, surgery remains the first-choice treatment for patients with N2 NSCLC if feasible.
Suyu Wang   +7 more
doaj   +1 more source

Successful treatment of late onset empyema after extrapleural pneumonectomy: A case report

open access: yesRespiratory Medicine Case Reports, 2019
Treatment of post-extrapleural pneumonectomy empyema (PEPPE) is more difficult than that for post-pneumonectomy empyema for two reasons: first, a large infectious dead space remains after extrapleural pneumonectomy (EPP); and second, defects of the ...
Shigeto Nishikawa   +3 more
doaj   +1 more source

Factors and outcomes associated with successful minimally invasive pneumonectomyCentral MessagePerspective

open access: yesJTCVS Open
Objective: To test the hypothesis that patients undergoing minimally invasive pneumonectomy at high-volume minimally invasive lung surgery centers have improved survival compared with patients who undergo open pneumonectomy.
Winston L. Trope, BE   +8 more
doaj   +1 more source

Pneumonectomy for Primary Lung Tumors and Pulmonary Metastases: A Comprehensive Study of Postoperative Morbidity, Early Mortality, and Preoperative Clinical Prognostic Factors

open access: yesCurrent Oncology, 2023
Background: Pneumonectomy is a major surgical resection that still remains a high-risk operation. The current study aims to investigate perioperative risk factors for postoperative morbidity and early mortality after pneumonectomy for thoracic ...
Konstantinos Grapatsas   +8 more
doaj   +1 more source

Risk Prediction Models for Recurrence After Curative Treatment of Early‐Stage or Locally Advanced Lung Cancer: A Systematic Review

open access: yesAging and Cancer, EarlyView.
This systematic review synthesizes prognostic models for survival and recurrence in resected non‐small cell lung cancer. While many models demonstrate moderate to good discrimination, few are externally validated and reporting quality is variable, limiting clinical applicability and highlighting the need for robust, transparent model development ...
Evangeline Samuel   +4 more
wiley   +1 more source

A rare cause of dyspnea on exertion with a cardiopulmonary exercise stress test

open access: yesRespiratory Medicine Case Reports
Informative abstract: Background: It is rare for an adult patient to be living decades after a pneumonectomy procedure. This case features complications that can arise.
Elizabeth H. Lees   +6 more
doaj   +1 more source

The Diagnostic Value of Immunohistochemistry and Biomarkers in the Diagnosis of Mesothelioma in Pleural/Peritoneal Effusions

open access: yesDiagnostic Cytopathology, EarlyView.
ABSTRACT Background Mesothelioma is a rare tumor that arises from the serosal cells lining the serous cavities, most commonly the pleura followed by the peritoneum. Presenting symptoms include pleuritic pain and bloody effusions that recur. Although cytologic analysis cannot determine the mesothelial subtype or in situ from invasive disease, the ...
Suzanne M. Selvaggi
wiley   +1 more source

Scintigraphic Assessment of Pulmonary Flow in Patients After Pneumonectomy

open access: yesDiagnostics
Background: Pulmonary circulation typically shows flow divided between the right and left lungs, with a marked predominance of the right lung.
Bogumił Maciąg   +8 more
doaj   +1 more source

Nuclear factor-kappa B influences early phase of compensatory lung growth after pneumonectomy in mice

open access: yesJournal of Biomedical Science, 2017
Background Compensatory lung growth (CLG) is a well-established lung regeneration model. However, the sequential mechanisms, including unknown molecular triggers or regulators, remain unclear.
Yusuke Takahashi   +5 more
doaj   +1 more source

Pneumonectomy for Non-small Cell Lung Cancer: Predictors of Operative Mortality and Survival

open access: yesChinese Journal of Lung Cancer, 2020
Surgery is the most effective way to cure non-small cell lung cancer currently. Although sleeve lobectomy, with less reduction of respiratory function and a lower mortality rate, would not compromise oncological results in well-selected patients with ...
Xiaokang GUO, Huafeng WANG, Yucheng WEI
doaj   +1 more source

Home - About - Disclaimer - Privacy